日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity.

通过维拉帕米介导的DNA损伤驱动的细胞毒性促进作用,克服卵巢癌细胞获得的阿霉素耐药性。

Mukinovic Elvira, Federmann Sina, Messling Larissa, Sekeres Marlena, Mann Julia, Abbey Lena, Kassack Matthias U, Fritz Gerhard

In vitro characterization of the catalytic domain of human histone deacetylase 5

人组蛋白去乙酰化酶5催化结构域的体外表征

Mammen, Christian; Hornung, Fenja M; Anzenhofer, Christian; Schumacher, Julia; Reiners, Jens; Li, Jingyu; Mazzone, Flaminia; Bilsing, Florestan L; Kassack, Matthias U; Kurz, Thomas; Smits, Sander H J

Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties.

探索组蛋白去乙酰化酶 (HDAC) 抑制剂中的替代锌结合基团,发现 DS-103 是一种具有化学增敏特性的强效乙基肼基 HDAC 抑制剂

Stopper Daniel, Biermann Lukas, Watson Paris R, Li Jingyu, König Beate, Gaynes Matthew N, Pessanha de Carvalho Lais, Klose Jana, Hanl Maria, Hamacher Alexandra, Schäker-Hübner Linda, Ramsbeck Daniel, Held Jana, Christianson David W, Kassack Matthias U, Hansen Finn K

YAK577 Attenuates Cardiac Remodeling and Fibrosis in Isoproterenol-Infused Heart Failure Mice by Downregulating MMP12.

YAK577 通过下调 MMP12 来减轻异丙肾上腺素输注心力衰竭小鼠的心脏重塑和纤维化

Zhou Hongyan, Kee Hae Jin, Wan Le, Asfaha Yodita, Fischer Fabian, Kassack Matthias U, Kurz Thomas, Kim Seong Hoon, Kee Seung-Jung, Hong Young Joon, Jeong Myung Ho

The Antioxidant and HDAC-Inhibitor α-Lipoic Acid Is Synergistic with Exemestane in Estrogen Receptor-Positive Breast Cancer Cells

抗氧化剂和 HDAC 抑制剂 α-硫辛酸与依西美坦在雌激素受体阳性乳腺癌细胞中具有协同作用

Laura S Pradel, Yu-Lin Ho, Holger Gohlke, Matthias U Kassack

Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer

恩替诺特(一种溴结构域抑制剂)和顺铂的三联疗法是治疗膀胱癌的一种有前途的治疗选择

Lukas M Bollmann, Friedrich Lange, Alexandra Hamacher, Lukas Biermann, Linda Schäker-Hübner, Finn K Hansen, Matthias U Kassack

Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)

新型组蛋白去乙酰化酶 (HDAC) 抑制剂通过上调 E-钙粘蛋白诱导胰腺导管腺癌 (PDAC) 细胞凋亡并抑制侵袭

Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, Alexandra Hamacher, Jan Hänsel, Matthias U Kassack, Thomas Kurz, Nicole E Teusch

Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells

IIa 类 HDAC 抑制剂 CHDI0039 与硼替佐米在头颈癌细胞中的协同作用

Christian Schrenk, Lukas M Bollmann, Corinna Haist, Arthur Bister, Constanze Wiek, Maria Wecker, Dennis Roth, Patrick Petzsch, Karl Köhrer, Alexandra Hamacher, Helmut Hanenberg, Georg Fluegen, Matthias U Kassack

The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines

新型 IIa 类选择性组蛋白去乙酰化酶抑制剂 YAK540 与硼替佐米在白血病细胞系中具有协同作用

Lukas M Bollmann, Alexander J Skerhut, Yodita Asfaha, Nadine Horstick, Helmut Hanenberg, Alexandra Hamacher, Thomas Kurz, Matthias U Kassack

Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors

烷氧基酰胺类组蛋白去乙酰化酶抑制剂协同诱导耐药头颈癌和白血病细胞凋亡

Leandro A Alves Avelar, Christian Schrenk, Melf Sönnichsen, Alexandra Hamacher, Finn K Hansen, Julian Schliehe-Diecks, Arndt Borkhardt, Sanil Bhatia, Matthias U Kassack, Thomas Kurz